About this episode

This episode discusses advanced management strategies for uncontrolled and resistant hypertension, focusing on the role of aldosterone.

Uncontrolled and resistant hypertension is more common than we think. In the second episode of this special three-part series, Dr. Neil Skolnik discusses management strategies, but also explores our new understanding of aldosterone and its stealth role in hypertension. This series is supported with support from AstraZeneca . Please listen to the episodes by clicking on the podcast player below or by freely subscribing to DOC Updates via Apple Podcasts , Amazon Music , Spotify , or your preferred podcast platform. Presented by: Neil Skolnik , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Payal Kohli , MD, Harvard-educated preventive cardiologist and the Founder and Medical Director of Cherry Creek Heart​ in Aurora Colorado, Associate Adjunct Professor in Cardiology at Johns Hopkins University, and Associate Adjunct Professor in Cardiology at Duke University Selected references: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults…

People in this episode

Host: Neil Skolnik

Guest: Payal Kohli

Topics covered

• hypertension
• aldosterone
• cardiology
• blood pressure management
• resistant hypertension
• healthcare strategies

Keywords

• hypertension
• aldosterone
• cardiology
• blood pressure
• resistant hypertension
• health management
• AstraZeneca

Sponsors

AstraZeneca

Mentioned in this episode

Organizations: American Diabetes Association, Sidney Kimmel Medical College, Thomas Jefferson University, Abington Jefferson Health, Johns Hopkins University, Duke University

Books & works: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults, Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis, Efficacy and Safety of Baxdrostat in Uncontrolled

More episodes of DOC Updates

• Special Edition: Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) · September 3, 2026 · 23 min
• Special Edition: Evidence-Based Strategies for Weight Loss and Long-Term Weight Maintenance · August 24, 2026 · 32 min
• Special Edition: What's Next—The Role of Health Systems in Managing CKD Associated with T1D & T2D · August 17, 2026 · 33 min
• Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more! · August 10, 2026 · 36 min
• Impact of Finerenone on Albuminuria in T1D, National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs, and more! · August 10, 2026 · 32 min
• Special Edition: Hypertension Part I—Overview and Management · August 6, 2026 · 34 min

Explore listener stats, chart rankings, contacts and more on the DOC Updates podcast page.